Chester County News and Community Website
KING OF PRUSSIA, PA — A coalition of major nonprofit research organizations has awarded $2.1 million in grants to accelerate the development of diagnostic biomarkers for frontotemporal degeneration, aiming to …
$2.1M Push Targets Faster, Clearer Diagnosis for Elusive Dementia Disorder Read More
GENT, Belgium & MALVERN, PA & TOKYO, Japan — H.U. Group Holdings Inc. and its subsidiary Fujirebio have announced the launch of the Lumipulse G sTREM2 assay, a chemiluminescent enzyme …
Fujirebio Launches sTREM2 Assay to Advance Neuroinflammation Research Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has cleared a first-of-its-kind blood test designed to aid in the diagnosis of Alzheimer’s disease, a progressive neurodegenerative disorder affecting …
Groundbreaking Blood Test Offers New Hope for Alzheimer’s Diagnosis Read More
SAN DIEGO, CA / TOKYO, Japan / MALVERN, PA — Fujirebio Holdings Inc., its subsidiary Fujirebio Diagnostics, Inc., and AriBio Co., Ltd. have announced the successful completion of a prospective …
Fujirebio and AriBio Achieve Milestone in Biomarker Advancement for Alzheimer’s Disease Read More
DOYLESTOWN, PA — Incite Health, Inc. commended Governor Shapiro for signing House Bill 1754 into law on July 1, 2027. This groundbreaking legislation mandates comprehensive biomarker testing coverage by all …
Pennsylvania Expands Access to Precision Medicine with New Biomarker Testing Law Read More